APA (7th ed.) Citation

Makhloufi, A., Ghemit, R., El Kolli, M., & Baitiche, M. (2023). Computational investigation into Nirematrelvir/Ritonavir synergetic efficiency compared with some approved antiviral drugs targeting main protease (Mpro) SARS-CoV-2 Omicron variant. Journal of the Indian Chemical Society, 100(3), 100891. https://doi.org/10.1016/j.jics.2023.100891

Chicago Style (17th ed.) Citation

Makhloufi, Abdesselam, Rima Ghemit, Meriem El Kolli, and Milad Baitiche. "Computational Investigation into Nirematrelvir/Ritonavir Synergetic Efficiency Compared with Some Approved Antiviral Drugs Targeting Main Protease (Mpro) SARS-CoV-2 Omicron Variant." Journal of the Indian Chemical Society 100, no. 3 (2023): 100891. https://doi.org/10.1016/j.jics.2023.100891.

MLA (9th ed.) Citation

Makhloufi, Abdesselam, et al. "Computational Investigation into Nirematrelvir/Ritonavir Synergetic Efficiency Compared with Some Approved Antiviral Drugs Targeting Main Protease (Mpro) SARS-CoV-2 Omicron Variant." Journal of the Indian Chemical Society, vol. 100, no. 3, 2023, p. 100891, https://doi.org/10.1016/j.jics.2023.100891.